Navigation Links
Statins Show Promise for Blood Clot Prevention
Date:10/27/2008

PHILADELPHIA, Oct. 27 /PRNewswire/ -- Statins, the class of drugs commonly used for lowering cholesterol, are now showing promise at preventing deep vein thrombosis (DVT) or blood clots, an affliction that occurs in nearly 2 million Americans each year. New research presented at CHEST 2008, the 74th annual international scientific assembly of the American College of Chest Physicians (ACCP), suggests that the use of statins may be associated with a significant reduction in the occurrence of venous thromboembolism (VTE), a condition that includes DVT and pulmonary embolism, in patients with solid organ tumors, including breast, lung, and colon cancers.

"The results of our research are interesting and thought provoking," said study author Danai Khemasuwan, MD, Albert Einstein Medical Center, Philadelphia, PA. "We hope that our research alerts the scientific community to the potential of statins in reducing VTE."

Dr. Khemasuwan and his colleagues from Albert Einstein Medical Center evaluated the influence of statins use on the incidence of VTE by reviewing 740 consecutive patients admitted to the hospital between October 2004 and September 2007 with a diagnosis of breast, lung, colon, prostate, stomach, esophagus, pancreas, ovary, kidney, or brain cancer. The occurrence of VTE, risk factors for VTE, and use of statins were recorded. Patients who either used statins for less than 2 months or who never used statins were allocated to the control group.

The mean age of the entire study population was 65 years, 52 percent of subjects were women, and 76 percent were African-American. A total of 26 percent of patients received statins, and the overall incidence of VTE was 18 percent. The analysis revealed that patients receiving statins were significantly less likely to develop VTE than the control group, with 8 percent of patients receiving statins developing VTE compared with 21 percent in the control group. A logistical regression analysis yielded the same results irrespective of smoking, documented metastatic disease, current use of chemotherapy, immobilization, and use of aspirin.

Although the authors could not draw conclusions about the cause and effect relationship between statins and VTE, Dr. Khemasuwan feels the data are promising. "If the results of our study are confirmed in a prospective randomized, controlled trial, this could have very significant implications for the medical community."

"Recent studies have examined the use of statins for the prevention of lung disease, stroke, and other neurologic disorders," said James A. L. Mathers, Jr., MD, FCCP, President of the American College of Chest Physicians. "The results of this study are promising and suggest a potential role for statins in the prevention of thromboembolism."

CHEST 2008 is the 74th annual international scientific assembly of the American College of Chest Physicians, held October 25-30 in Philadelphia, PA. ACCP represents 17,000 members who provide patient care in the areas of pulmonary, critical care, and sleep medicine in the United States and throughout the world. The ACCP's mission is to promote the prevention and treatment of diseases of the chest through leadership, education, research, and communication. For more information about the ACCP, please visit the ACCP Web site at http://www.chestnet.org.


'/>"/>
SOURCE American College of Chest Physicians
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Statins Help Obese People After Bypass Surgery
2. Research Shows Why Statins Dont Work for Everyone
3. Statins May Help Older Women Control Irregular Heartbeat
4. When statins arent enough: New trial drug points to better management of coronary heart disease
5. iGuard.org Presents New Data on Statins at FDA Workshop Demonstrating How Patient-Reported Information Can Enhance Drug Safety Knowledge
6. Women are treated less frequently than men with statins, aspirin and beta-blockers
7. Cholesterol-Lowering Statins Tied to Tendon Woes
8. Tendon complications, though rare, linked to statins
9. New Gene-Based Therapy an Alternative to Vytorin and Statins in Heart Disease Prevention and Treatment
10. Latest Study Says Statins Dont Slow Alzheimers
11. Statins After Bypass Lower Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... , ... May 22, 2017 , ... Faithfully following pop ... body squatted, stretched, jumped, toned and shaped through fitness programs. It carries on to ... course, finished off with an irresistible, radiant smile. CDA has found that ...
(Date:5/21/2017)... ... 2017 , ... HealthSmart, the largest independent benefits administrator in ... Chief Information Officer (CIO). He will be joining HealthSmart at the end of ... He defines strategic roadmaps by reimagining business processes—bridging the gap between information technology ...
(Date:5/21/2017)... ... May 21, 2017 , ... For the past ... group of scholars, policymakers, and activists wanting to address equity issues in breastfeeding, ... the third book from a recent series of from this conference. , ...
(Date:5/21/2017)... ... May 21, 2017 , ... Dental visits ... six months since you've seen a dentist, it's time for a dental checkup. ... x-rays once per year. , Dental checkups are a relatively easy procedure that ...
(Date:5/19/2017)... ... , ... When Kyle Busch graduates from Kansas City University of Medicine and ... research studies that could impact the health of young athletes everywhere. , As a ... orthopedic surgeon, alongside an international team trying to discover why girls involved in pivot-shifting ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it is teaming up with ... Limited to lower diabetes healthcare costs in ... which is available throughout all provinces and territories in ... eligible for additional savings when shopping for Dario supplies ...
(Date:5/4/2017)... May 4, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade hypothermic storage ... the "Company"), today announced that the Company,s first quarter ... on Thursday, May 11, 2017, and that the Company ... 1:30 p.m. PT that afternoon. Management will provide an ...
(Date:5/3/2017)... May 3, 2017  Kalorama Information notes that ... percent next year and this is projected to ... stem cell (HSCT) or bone marrow transplants require ... are well-suited for this task. This according to ... Kalorama Information. The various PCR-based methodologies, Sanger sequencing ...
Breaking Medicine Technology: